The Issue: it’s a data problem, not a people problem.

Current volatility and the upcoming surge and shift in elective surgeries is forcing medical device company leaders to rethink existing business models.

“Flatten the curve” has become the mantra of Covid-19 response resulting in stay-at-home advisories excluding essential travel, social distancing, and postponing elective surgeries.

Bain & Company's research suggests that surgeons at ASCs are more likely to change medical devices than their peers within hospital settings.

Modern technology has revolutionized countless industries over the last few decades including finance, retail, automobiles, and even Major League Baseball.

Coming to the Becker's ASCConference, June 13th and 14th in Chicago? Stop by Booth 73T to learn more about Relatable and to enter our raffle for Bose headphones!

Growing numbers of orthopedic, spine, and cardiovascular procedures in Ambulatory Surgery Centers (ASCs) will change the status quo in implantable medical device contracting.